MAPT and Alzheimer disease: Intriguingly, the activity of PON1 per APOA1, that likely reflects the antioxidant protection of this apolipoprotein, emerged as a predictor of t-tau in AD patients, suggesting a potential prognostic usefulness of this parameter in affected individuals.